Thus, tumor tissue from patients with surgically incurable parathyroid cancer can rationally be subjected to DNA sequencing, with patients proving to harbor clonal somatic activating PIK3CA mutations being considered for appropriately targeted treatment,2, 6 ideally in the setting of a study. The gene discussed is PIK3CA; the disease is malignant tumor of parathyroid gland.